After finishing at $6.17 in the prior trading day, Applied Therapeutics Inc (NASDAQ: APLT) closed at $6.46, up 4.70%. In other words, the price has increased by $+0.29 from its previous closing price. On the day, 1392803 shares were traded.
Ratios:
Our goal is to gain a better understanding of APLT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.80 and its Current Ratio is at 0.80.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on February 22, 2024, initiated with a Outperform rating and assigned the stock a target price of $12.
On January 04, 2022, Barclays Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $44 to $7.
Goldman Downgraded its Neutral to Sell on August 27, 2021, whereas the target price for the stock was revised from $16 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 01 ’23 when Kanter Stacy J. bought 30,000 shares for $2.18 per share. The transaction valued at 65,367 led to the insider holds 63,000 shares of the business.
Shendelman Shoshana sold 3,968 shares of APLT for $7,817 on Nov 30 ’23. The President and CEO now owns 2,596,387 shares after completing the transaction at $1.97 per share. On Nov 30 ’23, another insider, Perfetti Riccardo, who serves as the Chief Medical Officer of the company, sold 1,583 shares for $1.97 each. As a result, the insider received 3,119 and left with 692,341 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLT now has a Market Capitalization of 555.92M and an Enterprise Value of 519.78M. For the stock, the TTM Price-to-Sale (P/S) ratio is 54.60. Its current Enterprise Value per Revenue stands at 48.76 whereas that against EBITDA is -8.38.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $9.39, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 3.65, while the 200-Day Moving Average is calculated to be 2.33.
Shares Statistics:
The stock has traded on average 2.29M shares per day over the past 3-months and 3.32M shares per day over the last 10 days, according to various share statistics. A total of 90.10M shares are outstanding, with a floating share count of 61.79M. Insiders hold about 31.42% of the company’s shares, while institutions hold 61.20% stake in the company. Shares short for APLT as of Feb 15, 2024 were 3.87M with a Short Ratio of 1.69, compared to 3.63M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 5.01% and a Short% of Float of 5.96%.
Earnings Estimates
Its stock is currently analyzed by 4 different market analysts. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.31, while EPS last year was -$0.16. The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.15 and low estimates of -$0.23.
Analysts are recommending an EPS of between -$1.2 and -$1.71 for the fiscal current year, implying an average EPS of -$1.42. EPS for the following year is -$0.84, with 4 analysts recommending between -$0.58 and -$1.21.
Revenue Estimates
Based on 3 analysts’ estimates, the company’s revenue will be $10.17M in the next fiscal year. The high estimate is $16.73M and the low estimate is $6.28M. The average revenue growth estimate for next year is down -4.70% from the average revenue estimate for this year.
